Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China

References

• Islas-Muñoz B, Volkow-Fernández P, Ibanes-Gutiérrez C, Villamar-Ramírez A, Vilar-Compte D, Cornejo-Juárez P. Bloodstream infections in cancer patients. Risk factors associated with mortality. Int J Infect Dis. 2018;71:59–64. doi:10.1016/j.ijid.2018.03.022
   PubMed Web of Science ®Google Scholar
• Jiang ZQ, Wang SD, Feng DD, Zhang BX, Mao SH, Wu JN. Epidemiological risk factors for nosocomial bloodstream infections: a four-year retrospective study in China. J Crit Care. 2019;52:92–96. doi:10.1016/j.jcrc.2019.04.019
   PubMed Web of Science ®Google Scholar
• Liang T, Xu C, Cheng Q, Tang Y, Zeng H, Li X. Epidemiology, risk factors, and clinical outcomes of bloodstream infection due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hematologic malignancy: a retrospective study from Central South China. Microb Drug Resist. 2021;27:800–808. doi:10.1089/mdr.2020.0033
   Web of Science ®Google Scholar
• Al-Hasan MN Gram-negative bloodstream infection: implications of antimicrobial resistance on clinical outcomes and therapy. Antibiotics-Basel. 2020;9(12):922. doi:10.3390/antibiotics9120922
   Web of Science ®Google Scholar
• Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014;6:25–64.
   PubMedGoogle Scholar
• Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018;67:1803–1814.
   PubMed Web of Science ®Google Scholar
• Kadri SS, Lai Y, Ricotta EE, et al. External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals. Open Forum Infect Dis. 2019;6:ofz110.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Vena A, Sepulcri C, Giacobbe DR, Peghin M. Treatment of bloodstream infections due to gram-negative bacteria with difficult-to-treat resistance. Antibiotics. 2020;9:632.
   Web of Science ®Google Scholar
• Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21:241–251.
   PubMed Web of Science ®Google Scholar
• Cain SE, Kohn J, Bookstaver PB, Albrecht H, Al-Hasan MN Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother 2015;59(1):245–250. doi:10.1128/AAC.03935-14
   PubMed Web of Science ®Google Scholar
• Zhu S, Kang Y, Wang W, Cai L, Sun X, Zong Z The clinical impacts and risk factors for non-central line-associated bloodstream infection in 5046 intensive care unit patients: an observational study based on electronic medical records. Crit Care 2019;23(1):52. doi:10.1186/s13054-019-2353-5
   PubMed Web of Science ®Google Scholar
• Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes 2015;8(1):742. doi:10.1186/s13104-015-1701-z
   Google Scholar
• Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013;19(5):474–479. doi:10.1111/j.1469-0691.2012.03879.x
   PubMed Web of Science ®Google Scholar
• Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med 2020;46(2):266–284. doi:10.1007/s00134-020-05950-6
   PubMed Web of Science ®Google Scholar
• O’, Grady NP, Alexander M, Burns LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52(9):1087–1099. doi:10.1093/cid/cir138
   Web of Science ®Google Scholar
• See I, Mu Y, Albrecht V, et al. Trends in incidence of methicillin-resistant staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005–2013. Clin Infect Dis 2020;70(1):19–25. doi:10.1093/cid/ciz158
   Web of Science ®Google Scholar
• Song F, Zhang K, Huang J, et al. Clinical characteristics, risk factors, and outcomes of patients with polymicrobial Klebsiella pneumoniae bloodstream infections. Biomed Res Int 2021;2021:6619911. doi:10.1155/2021/6619911
   PubMed Web of Science ®Google Scholar
• Moghnieh R, Estaitieh N, Mugharbil A, et al. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Front Cell Infect Microbiol 2015;5:11. doi:10.3389/fcimb.2015.00011
   PubMed Web of Science ®Google Scholar
• Bindschedler A, Wacker R, Egli J, et al. Plasmodium berghei sporozoites in nonreplicative vacuole are eliminated by a PI3P-mediated autophagy-independent pathway. Cell Microbiol 2021;23(1):e13271. doi:10.1111/cmi.13271
   Web of Science ®Google Scholar
• Liu J, Fang Z, Yu Y, et al. Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017–2019. Antimicrob Resist Infect Control 2021;10(1):121. doi:10.1186/s13756-021-00989-6
   PubMed Web of Science ®Google Scholar
• Chen S, Lin K, Li Q, et al. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy. J Cancer 2021;12(18):5494–5505. doi:10.7150/jca.50802
   PubMed Web of Science ®Google Scholar
• Gubbels S, Nielsen J, Voldstedlund M, et al. Utilization of blood cultures in Danish hospitals: a population-based descriptive analysis. Clin Microbiol Infect 2015;21:344.e13-21. 4 doi:10.1016/j.cmi.2014.11.018
   Web of Science ®Google Scholar
• Santella B, Folliero V, Pirofalo GM, et al. Sepsis-A retrospective cohort study of bloodstream infections. Antibiotics 2020;9(12). doi:10.3390/antibiotics9120851
   Web of Science ®Google Scholar
• da Silva N, da Rocha JA, Do Valle FM, Silva A, Ehrlich S, Martins IS. The impact of ageing on the incidence and mortality rate of bloodstream infection: a hospital-based case-cohort study in a tertiary public hospital of Brazil. Trop Med Int Health 2021;26(10):1276–1284 doi:10.1111/tmi.13650
   PubMed Web of Science ®Google Scholar
• Serra N, Di Carlo P, D’ Arpa F, et al. Human bile microbiota: a retrospective study focusing on age and gender. J Infect Public Health 2021;14(2):206–213. doi:10.1016/j.jiph.2020.11.005
   Web of Science ®Google Scholar
• Licata F, Quirino A, Pepe D, Matera G, Bianco A, Group C Antimicrobial resistance in pathogens isolated from blood cultures: a two-year multicenter hospital surveillance study in Italy. Antibiotics 2020;10(10). doi:10.3390/antibiotics10010010
   Web of Science ®Google Scholar
• Brannon JR, Dunigan TL, Beebout CJ, et al. Invasion of vaginal epithelial cells by uropathogenic Escherichia coli. Nat Commun 2020;11(1):2803. doi:10.1038/s41467-020-16627-5
   PubMed Web of Science ®Google Scholar
• Amanati A, Sajedianfard S, Khajeh S, et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect Dis. 2021;21(1):636. doi:10.1186/s12879-021-06243-z
   PubMed Web of Science ®Google Scholar
• Nestor D, Andersson H, Kihlberg P, et al. Early prediction of blood stream infection in a prospectively collected cohort. BMC Infect Dis 2021;21(1):316. doi:10.1186/s12879-021-05990-3
   Web of Science ®Google Scholar
• Habyarimana T, Murenzi D, Musoni E, Yadufashije C, Niyonzima FN Bacteriological profile and antimicrobial susceptibility patterns of bloodstream infection at Kigali University Teaching Hospital. Infect Drug Resist 2021;14:699–707. doi:10.2147/IDR.S299520
   Web of Science ®Google Scholar
• Santoro A, Franceschini E, Meschiari M, et al. Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: impact of MDR and XDR bacteria. Open Forum Infect Dis 2020;7:ofaa461. 11 doi:10.1093/ofid/ofaa461
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang S, Yang M, Bao J, Wang C. Analysis of risk factors and clinical indicators in bloodstream infections among patients with hematological malignancy. Cancer Manag Res. 2020;12:13579–13588. doi:10.2147/CMAR.S289291
   PubMed Web of Science ®Google Scholar
• Di Carlo P, Serra N, Lo Sauro S, et al. Epidemiology and pattern of resistance of gram-negative bacteria isolated from blood samples in hospitalized patients: a single center retrospective analysis from Southern Italy. Antibiotics 2021;10. doi:10.3390/antibiotics11010010
   Web of Science ®Google Scholar
• Saliba R, Ghelfenstein-Ferreira T, Lomont A, et al. Risk factors for the environmental spread of different multidrug-resistant organisms: a prospective cohort study. J Hosp Infect 2021;111:155–161. doi:10.1016/j.jhin.2021.01.029
   Web of Science ®Google Scholar
• Trecarichi EM, Tumbarello M Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr Opin Infect Dis 2014;27(2):200–210. doi:10.1097/QCO.0000000000000038
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Tumbarello M, Caira M, et al. Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies. Haematologica 2011;96(1):e1–3; author reply e4. doi:10.3324/haematol.2010.036640
   Web of Science ®Google Scholar
• Fortún J, Sanz MÁ, Madero L, et al. Update on bacteraemia in oncology and hematology. Enferm Infecc Microbiol Clin 2011;29(Suppl 4):48–53. doi:10.1016/S0213-005X(11)70036-2
   Google Scholar
• Cornejo-Juárez P, Pérez-Jiménez C, Silva-Sánchez J, et al. Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies. PLoS One 2012;7(4):e35780. doi:10.1371/journal.pone.0035780
   Web of Science ®Google Scholar
• Trecarichi EM, Pagano L, Candoni A, et al. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect 2015;21(4):337–343. doi:10.1016/j.cmi.2014.11.022
   PubMed Web of Science ®Google Scholar
• Lye DC, Earnest A, Ling ML, et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2012;18:502–508.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34:1600–1606.
   PubMed Web of Science ®Google Scholar
• Papakonstantinou I, Angelopoulos E, Baraboutis I, et al. Risk factors for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens in mechanically ventilated ICU patients. J Chemother. 2015;27:283–289.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhuang S, Du M. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China. Infection. 2007;35:339–345.
   Web of Science ®Google Scholar
• Villafuerte D, Aliberti S, Soni NJ, et al. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology. 2020;25:543–551.
   PubMed Web of Science ®Google Scholar
• Tian X, Huang C, Ye X, et al. Molecular epidemiology of and risk factors for extensively drug-resistant Klebsiella pneumoniae infections in Southwestern China: a retrospective study. Front Pharmacol. 2019;10:1307.
   Web of Science ®Google Scholar
• Ruppé E, Andremont A, Armand-Lefèvre L. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: an update. Travel Med Infect Dis. 2018;21:28–35.
   Web of Science ®Google Scholar
• Bell T, O’ Grady NP. Prevention of central line-associated bloodstream infections. Infect Dis Clin North Am. 2017;31:551–559.
   Web of Science ®Google Scholar
• Aminzadeh Z, Simpson P, Athan E. Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: epidemiology, microbiology and outcomes. Infect Dis Health. 2019;24:222–228.
   PubMed Web of Science ®Google Scholar
• Halaji M, Shahidi S, Ataei B, Atapour A, Feizi A, Havaei SA. Molecular epidemiology of blaCTX-M gene-producing uropathogenic Escherichia coli among Iranian kidney transplant patients: clonal dissemination of CC131 and CC10. Ann Clin Microbiol Antimicrob. 2021;20(1):65.
   Web of Science ®Google Scholar
• Halaji M, Shahidi S, Atapour A, Ataei B, Feizi A, Havaei SA. Characterization of extended-spectrum β-lactamase-producing uropathogenic Escherichia coli among Iranian kidney transplant patients. Infect Drug Resist. 2020;13:1429–1437.
   PubMed Web of Science ®Google Scholar
• Ghassabi F, Hashempour T, Moghadami M, et al. Bacterial etiology and antibiotic resistance pattern of septicemia in HIV and non-HIV patients admitted to tertiary care hospitals, Shiraz, South of Iran. Cell Mol Biol. 2017;63(9):115–121.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Carnelutti A, Peghin M. Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti Infect Ther. 2017;15:55–65.
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Cohen N, Ma KC, et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73:336–345.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin Q, Chen Z, et al. Construction of a risk prediction model for subsequent bloodstream infection in intestinal carriers of Carbapenem-Resistant Enterobacteriaceae: a retrospective study in hematology department and intensive care unit. Infect Drug Resist. 2021;14:815–824.
   Web of Science ®Google Scholar
• Halaji M, Fayyazi A, Rajabnia M, Zare D, Pournajaf A, Ranjbar R. Phylogenetic group distribution of uropathogenic Escherichia coli and related antimicrobial resistance pattern: a meta-analysis and systematic review. Front Cell Infect Microbiol. 2022;12:790184.
   Web of Science ®Google Scholar